Re:Opaque drug pricing in the U.S.
by saycheese on Sunday March 12, 2017 @04:41PM
(#13852971)
Worth noting this was "Issued by Global Policy & International Public Affairs, Pfizer Inc." (a large pharmaceuticals company) in October 2015 and there is an odd phrase in the footer that reads "Do Not Detail."
[ Parent
| on HN ]
"Detail", in pharma parlance, refers to making sales presentations to physicians. The people who do this were once called "detail men".[1] This has declined somewhat now that pharma can advertise prescription drugs directly to patients.
[1] https://www.theatlantic.com/magazine/archive/2006/04/the-dru...